Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

Merck Drug Price Row Loss, $56M Biotech Verdict And More No Photo Available

Law360 Healthcare Authority looks at a D.C. federal court's rejection of Merck's challenge to the Medicare drug price negotiation prog... (more story)

Hospitals Lean On Payors Amid ACA, Medicaid Cuts No Photo Available

Hospitals feeling a mounting financial squeeze are getting more aggressive in contract negotiations and reimbursement disputes with in... (more story)

Meet The Atty In Colo. Hospital Gender Care Lawsuit No Photo Available

Paula Greisen has represented clients in the LGBTQ+ community in major litigation over the past decade. In recent days, she helped sec... (more story)